They developed a novel QD-doped polystyrene nanoparticle-based LFT to detect two cancer biomarkers, i.e., cytokeratin-19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) in human serum samples. Here, CEACAM5 is linked to cancer.